S

St. James University Hospital | Oncology Clinical Research Facility

Research site
(Unclaimed)
Location
Street James's University Hospital Beckett Street, Leeds, Leeds, England

Site insights

Top conditions

Top treatments

VX-445
VX-121
Defibrotide
Rucaparib
Ripretinib
VX-561
Semaglutide
Hu5F9-G4
Sunitinib
Trastuzumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 37 total trials

A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

The purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in pa...

Active, not recruiting
Cystic Fibrosis
Drug: VX-121/TEZ/D-IVA

This is a Phase 3, randomized, multinational, double-blind, dual placebo-controlled, 4-arm study evaluating rucaparib and nivolumab as maintenance tr...

Active, not recruiting
FIGO Stage III-IV
Newly Diagnosed
Drug: Rucaparib
Drug: Placebo Oral Tablet

This is a Phase 3, 2-arm, randomized, open-label, global, multicenter study comparing the efficacy of ripretinib to sunitinib in participants with GI...

Enrolling
GIST
Drug: Sunitinib
Drug: Ripretinib

Patients with HER2-positive primary breast cancer (BC) who do not achieve complete response after appropriate neoadjuvant therapy are at higher risk...

Active, not recruiting
HER2-Positive Primary Breast Cancer
Residual Invasive Breast Cancer
Drug: DS-8201a
Drug: T-DM1

An open-label post authorization efficacy and safety study evaluating graft failure-free survival at 1-year in highly sensitized end-stage renal dise...

Enrolling
Kidney Transplantation in Highly Sensitized Patients
Other: Normal Transplantation Routine
Drug: Imlifidase
Locations recently updated

Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabe...

Enrolling
Non-alcoholic Steatohepatitis
Drug: Placebo
Drug: Semaglutide

Trial sponsors

Vertex Pharmaceuticals logo
AbbVie logo
Gilead Sciences logo
Jazz Pharmaceuticals logo
P
M
C
Daiichi Sankyo logo
Deciphera logo
E

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems